Objectives/Hypothesis: Black race is a risk factor for angioedema. The primary aim was to examine the relationship between race-ethnicity and risk factors for angioedema.
INTRODUCTION
Angioedema is the rapid swelling of skin and/or mucosal tissue, as well as of subcutaneous and/or submucosal tissues. 1, 2 Otorhinolaryngologists are often called to evaluate patients with angioedema because the condition commonly targets tissues of the lips, face, neck, and upper aerodigestive tract. There are two main etiologies of angioedema: one mechanism is mediated by mast-cell degranulation that leads to the release of vasoactive histamine, leukotrienes, and prostaglandins. 3 A second mechanism involves the generation of bradykinin from the complement system, 4,5 commonly caused by angiotensin-converting enzyme inhibitors (ACE-I). 6, 7 ACE-I-induced angioedema occurs in less than 1% of ACE-I users, and it is more common in African Americans. [8] [9] [10] [11] There has been literature exploring the possible genetic basis for this association [12] [13] [14] and there is evidence supporting that blacks have an increased sensitivity to bradykinin due to lower endogenous bradykinin levels. 15, 16 Over the past 30 years in the United States, 55% of angioedema deaths connected to ACE-I use were among blacks. 17 In contrast, 60% of hereditary angioedema cases in the United States are in Caucasian patients. 18 The relationship between race and the development of mastcell mediated angioedema is not clearly defined.
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MATERIALS AND METHODS

Case and Control Selection
Using a case-control study design, selected cases and controls were selected using the clinical research tool, Clinical Looking Glass (CLG, described in more detail below). Cases were defined as any emergency department (ED) visits with a primary or secondary International Classification of Diseases, Ninth Revision (ICD-9) code diagnosis of angioneurotic edema (995. 1) 
Clinical Looking Glass
CLG is a data collection and management software tool that assesses data from several electronic medical record and data collection systems that serve the Montefiore Healthcare System. This tool allows the user to rapidly acquire demographic, risk factor, and outcome data for patients in the Montefiore system in a de-identified fashion. Under a protocol approved by the Albert Einstein College of Medicine Institutional Review Board, a retrospective review of cases with and controls without angioedema was conducted using the CLG tool to collect data.
Variable Definitions
Demographic characteristics included age, gender, race, and ethnicity. These factors were collected from the patient on arrival to the ED. Medication history and risk factors were queried using CLG. ACE-I and angiotensin II receptor blockers (ARB) use were determined by record of an outpatient or inpatient medication prescription in the 5 years preceding cohort collection date. Body mass index (BMI) was determined by the most recent weight and height values entered into the medical record. Outpatient visit ICD-9 code diagnoses and problem lists determined history of hypertension, hyperlipidemia, allergic rhinitis, and smoking. Diabetes was determined by outpatient visit ICD-9 code diagnoses, problem lists, or lab tests of HbA1c > 7. Outpatient and ED visit ICD-9 code diagnoses and problem lists determined history of asthma, autoimmune disease, and eczema. Autoimmune disease included diagnoses of systemic erythematous lupus, rheumatoid arthritis, and their complications. All risk factors were included if entered into the medical record from January 2000 to December 2013.
Variable Selection
Known risk factors were selected in part to validate the study design as well as quantify the influence of risk for these factors risk in the development of angioedema. These variables included black race, ACE-I use, ARB use, hypertension, female gender, and older age. To investigate the relationship between allergic variables and angioedema, atopy-related variables of allergic rhinitis, asthma, and autoimmune disease were included. Other exposures common within the cohort, such as diabetes, hyperlipidemia, and smoking, although not associated with angioedema, were chosen to adjust for potential differences between the groups.
Race and Ethnicity Categories
Race-ethnicity categories were determined by demographic questions that are routinely asked to patients on arrival to the ED about race (white, black or African American; Asian, Native Hawaiian or Pacific Islander; American Indian or Alaskan Native; multiracial; decline to answer) and ethnicity (not Hispanic or Latino, Hispanic or Latino, decline to answer). Information for these two variables were recorded in the electronic patient record and available in CLG.
Race and Ethnicity of the Bronx Population Compared to Control Cohort
In order to demonstrate that the Montefiore Healthcare system emergency services population is representative of the Bronx population at large, race and ethnicity of the Bronx population was compared to the control cohort using data derived from 2011 New York State Department of Health Census data. 20 
Statistical Analysis
Demographic characteristics were compared using Fisher's exact tests and chi-squared analyses. A two-sample z-test of proportions was used to compare the racial composition of the Bronx population to the control cohort. For all combinations of demographic characteristics and risk factors, Spearman's correlation coefficients were conducted to examine independence of variables.
In primary analyses, to test if ACE-I use and black race together as risk factors equal more than the sum of their separate risks, synergy was evaluated by creating an interaction term. In secondary analyses, to directly compare several risk factors in the development of angioedema, different risk factors were evaluated using logistic regression. Baseline models were adjusted for gender, age, race, facility, and hospital admission within 30 days of ED visit. In this case-control study design, the baseline model allows for adjustment for basic demographic variables. Hospital admission allows for proxy measure of severity of illness. Risk factors were then further evaluated using logistic regression in expanded models adjusted for baseline model variables and ethnicity, diabetes, hypertension, hyperlipidemia, smoking history, asthma, allergic rhinitis, eczema, autoimmune disease, and ACE-I and ARB use. The expanded models were included because the expanded variables allow for further adjustment of potential confounders.
Finally in tertiary analyses, to further explore the effects of race on angioedema risk factors, effect modification was evaluated by stratifying logistic regression models by race-ethnicity categories. Analyses were performed with Stata (StataCorp, College Station, TX), and statistical significance was defined as two-sided P < 0.05
RESULTS
Cases and Controls
There were 1,247 cases and a pool of 458,663 control patients identified using the CLG utility (Fig. 1) . A total of 6,500 individuals were randomly selected from the control pool to serve as the control cohort in our study, yielding a 1:5 ratio of cases to controls. The demographic characteristics of angioedema cases differed from controls where cases were more likely to be older; female; black; and have a history of diabetes, hypertension, hyperlipidemia, smoking, asthma, allergic rhinitis, eczema, and autoimmune disease (Table I ). There were no cases of hereditary angioedema collected using our capture methods. All cases of angioedema were classified as angioneurotic edema. For all combinations of demographic characteristics and risk factors, Spearman's correlation coefficients were conducted. All analyses showed independence of variables (data not shown).
Race and Ethnicity of the Bronx Population Compared to Control Cohort
Compared to the Bronx population, per the 2011 New York State Department of Health Census data, the control cohort did not have significantly different proportions of non-Hispanic whites (11.6% vs. 11.4%), nonHispanic blacks (31.8% vs. 30.7%), and Asian/Pacific Islanders (2.22% vs. 3.87%) ( Table II) . The control cohort had a significantly smaller proportion of Hispanics than the Bronx population (44.4% vs. 53.9%). Of note, the electronic medical record defined race as Asian or Hawaiian Native/Pacific Islander, so these groups were combined to form the Asian/Pacific Islander category. The New York State Department of Health defined race as Asian/Pacific Islander. The electronic medical record had more options, including American/Indian/Alaskan Native, multiracial, and decline to answer, which were not found in the Bronx census data race categories.
Synergy of Angiotensin-Converting Enzyme Inhibitor Use and Black Race
In primary analyses, ACE-inhibitor use and black race did not have a synergistic relationship (odds ratio [OR] 1.10, 95% confidence interval [CI] 0.80, 1.51); therefore, their combined risk did not equal more than the sum of their separate risks. 
Relative Influence of Risk Factors
In secondary analyses, logistic regression models were used to compare the relative influence of different risk factors (Table III) . Baseline models were adjusted for gender, age, race, facility, and hospital admission within 30 days of ED visit. Expanded models were adjusted for baseline variables in addition to ethnicity, hypertension, hyperlipidemia, smoking history, asthma, allergic rhinitis, *Subset of cohort includes all non-Hispanic black, non-Hispanic white, and Hispanic individuals (n 5 6,831). Logistic regression was used with a multivariate model adjusted for gender, age, hospital facility, and inpatient hospital admission within 30 days of emergency department visit. † Non-Hispanic black patients self-identified as black race and non-Hispanic ethnicity in the electronic medical record. ‡ Non-Hispanic white patients self-identified as white race and non-Hispanic ethnicity in the electronic medical record. § Hispanic patients self-identified as any race and Hispanic ethnicity in the electronic medical record. ACE-I 5 angiotensin-converting enzyme inhibitor; ARB 5 angiotensin II receptor blockers; CI 5 confidence interval; OR 5 odds ratio.
Effect Modification by Race-Ethnicity
Finally, in tertiary analyses, ACE-I use, hypertension, ARB use, smoking history, and diabetes were significantly associated with an increased risk of angioedema across all race-ethnicity categories (Table IV) 
DISCUSSION
ACE-I and black race were found to be the strongest factors in the development of angioedema, which is consistent with a number of other studies. [8] [9] [10] [11] However, ACE-I use and black race were not synergistic risk factors. Contrary to this study's findings, there is evidence in the literature that there may be synergy between ACE-I use and black race. There have been genetic polymorphisms in enzymes that breakdown bradykinin have been identified in the black population that could possibly contribute to the increased ACE-I angioedema observed in this group. [12] [13] [14] [15] [16] Observationally, blacks using ACE-I often present with angioedema to Bronx hospitals, and we hypothesized that there was potentially an interaction between both risk factors to further increase the risk. However, our analysis in a very large cohort of patients did not find this to be the case.
A number of other epidemiologic risk factors have been shown to be associated with an increased risk of developing angioedema. For ACE-I-induced angioedema, female gender, 22, 23 aged > 65 years, 11 history of drug or seasonal allergies, 11 smoking history, 24 ACE-I-induced cough, 25 concurrent nonsteroidal antiinflammatory drugs (NSAID) or aspirin use, 26 and exposure to certain immunosuppressant drugs among renal and cardiac transplant patients 24, 27 are all factors that have been reported to increase the risk of the development of angioedema. Although in baseline models many demographic, allergic, and cardiovascular risk factors increased the risk of angioedema, only ACE-I use, hypertension, black race, eczema, allergic rhinitis, female gender, and age remained significant risk factors in fully adjusted models. Presence of eczema and allergic rhinitis may be revealing the propensity toward atopy and IgE-mediated angioedema. ACE-I use, and therefore hypertension and black race, are wellestablished risk factors. Female gender is associated with ACE-I-induced angioedema, which was consistent with our results. 22, 23 Increasing age is an established risk factor for development of ACE-I angioedema, and our findings show age is a significant factor, independent of hypertension, ACE-I, and ARB use. However, due to limitations of CLG, the severity of hypertension or dose of hypertensive medication was not accounted for in the analyses, so it is possible that older adults are more severely affected due to more severe disease. 28 Our results suggest that there is effect modification by race-ethnicity of certain risk factors and the development of angioedema. History of eczema and allergic rhinitis were significantly associated with an increased risk of angioedema among non-Hispanic blacks and Hispanics. Autoimmune disease and asthma were associated with an increased risk among only Hispanics. Atopic disorders involving IgE-mediated hypersensitivity reactions include eczema, allergic rhinitis, and asthma. 29 Angioedema may be more likely in people affected by atopic disease due to a propensity for IgE-mediated immune response. Environmental factors influence the development of these diseases. For example, inner-city homes have a higher concentrations of certain indoor pollutants (e.g., second-hand smoke, nitrogen dioxide) and allergens (e.g., mice and cockroaches). 30, 31 These environmental factors may account for the association of increased risk of angioedema observed in our Bronx study. 32 Autoimmune disease is most common among women of reproductive age and non-Hispanic blacks and Hispanics. 33, 34 We can only speculate why angioedema might be more common in patients with autoimmune disease. There could possibly be a genetic predisposition, or perhaps this population has a higher exposure to NSAID; aspirin; ARBs; and ACE-I-drugs commonly used to treat arthritis, which are also known causes of angioedema-and treatments used for arthritis and autoimmune disease. More research is needed to further elucidate the mechanism behind our observation.
Lastly, female gender was associated with a significantly increased risk only among non-Hispanic blacks. ACE-I-induced angioedema is more common in women, and hereditary angioedema type III's mechanism is dependent on estrogen; both factors contribute to a female predominance of this disorder. 22, 23, 35, 36 Why there is an increased risk of angioedema in only nonHispanic black women is not clear. Also of note, our sample size in non-Hispanic whites was much smaller than the other race-ethnicity categories; therefore, subgroup analyses of that category in our study may be underpowered.
This study had many strengths, including a large data analysis in a high-risk population for angioedema. However, this study had a number of limitations. The New York State census data race-ethnicity definitions did not directly correspond to our CLG-generated categories, which could have led to the discordance between the percentage of Hispanics in the cohort and census data. The method of using CLG has many limitations, including the inability to ensure the accuracy of electronic medical record data, without individual chart retrieval and review, which was overly cumbersome given the study design and numbers of patients evaluated in this study. To account for potential bias, the large control group should have been prone to the same biases as the study cohort. The fact that data acquired using CLG is not granular enough to clearly differentiate the cause of angioedema among cases is an additional weakness of this study. Potential confounders that could not be adjusted in our analyses are socioeconomic class, country of origin, access to healthcare, healthcare literacy, severity of angioedema, and etiology of angioedema. Lastly, this research explores large epidemiologic trends based on CLG-generated variables and selfidentified race-ethnicity categories, and the underlying mechanism of the observed associations cannot be definitively determined without further studies using different designs and methods. More research is needed to further explore the interplay of race-ethnicity and risk factors for angioedema, possibly through prospective studies targeting specific risk groups and ethnic populations.
CONCLUSION
In sum, using a case-control study design in a highrisk population, ACE-I use and black race were not found to be synergistic risk factors in the development of angioedema among a diverse urban population. ACE-I use, black race, and hypertension were the most influential risk factors in the development of angioedema. Race-ethnicity was an effect modifier for the risk factors of female gender, asthma, eczema, and allergic rhinitis.
